Illinois General Assembly - Full Text of HR0103
Illinois General Assembly

  Bills & Resolutions  
  Compiled Statutes  
  Public Acts  
  Legislative Reports  
  IL Constitution  
  Legislative Guide  
  Legislative Glossary  

 Search By Number
 (example: HB0001)
Search Tips

Search By Keyword

Full Text of HR0103  103rd General Assembly




HR0103LRB103 31109 MST 57773 r


2    WHEREAS, The substance use and opioid use crises in
3Illinois are responsible for historically high rates of
4overdoses and overdose-related fatalities; and
5    WHEREAS, According to the State's own opioid data, use and
6misuse of opioids in Illinois also continues to have
7substantial associated public health consequences, including
8increased rates of infectious diseases such as hepatitis C and
9HIV, lost productivity in the workplace, crime, neonatal
10abstinence syndrome, and homelessness; and
11    WHEREAS, Substance use and opioid use are often
12detrimental to a person's mental health; access to innovative
13and evidence-based treatments that address substance use and
14opioid use can improve a patient's overall mental health; and
15    WHEREAS, Historically disadvantaged groups face additional
16barriers to treatment for substance use and opioid use
17disorders, such as a lack of affordable therapy, stigma, and
18unequal access to mental health treatment; mental health
19equity should focus on access to quality and appropriate
20healthcare services; and
21    WHEREAS, The purpose of many federal programs is to



HR0103- 2 -LRB103 31109 MST 57773 r

1provide resources to states for increasing access to
2FDA-approved medications for the treatment of substance use
3and opioid use disorder and for supporting the continuum of
4prevention, harm reduction, treatment, and recovery support
5services for opioid use disorder and other substance use
6disorders; and
7    WHEREAS, A prescription digital therapeutic, which
8utilizes both cognitive behavioral therapy and contingency
9management in the product to treat substance use disorder or
10opioid use disorder, is approved, cleared, or classified by
11the Food and Drug Administration under section 510(k), 513(f),
12or 515 of the Federal Food, Drug, and Cosmetic Act and requires
13a prescription under section 801.109 of title 21 of the Code of
14Federal Regulations (or any successor regulation); and
15    WHEREAS, Prescription digital therapeutics have the
16potential to significantly improve health care delivery to
17underserved populations because they transcend care access
18limitations due to geography, socioeconomic status, trust of
19traditional institutions, and more; and
20    WHEREAS, Clinical studies have shown significantly greater
21odds of stimulant and opioid abstinence during treatment if
22treatment as usual is combined with an FDA-authorized PDT that
23has both cognitive behavioral therapy and contingency



HR0103- 3 -LRB103 31109 MST 57773 r

1management; and
2    WHEREAS, A 2018 study demonstrated that when a Community
3Reinforcement Approach and Contingency Management are
4administered together then a patient is 2.84 times more likely
5to remain abstinent at the end of the treatment than those in
6other programs; and
7    WHEREAS, The White House's Office of National Drug Control
8Policy recently released its 2022 National Drug Control
9Strategy document; specifically, the document points to
10prescription digital therapeutics and how these tools could
11help increase services for a wide array of patients; and
12    WHEREAS, Federally-funded programs help many states to
13fund access to FDA-authorized PDTs for patients and providers;
14therefore, be it
17we urge the Department of Human Services and the Governor's
18Opioid Overdose Prevention and Recovery Steering Committee to
19closely consider funding FDA-authorized PDTs to help patients
20who are struggling with substance use and opioid use
21disorders; and be it further



HR0103- 4 -LRB103 31109 MST 57773 r

1    RESOLVED, That a suitable copy of this resolution be
2delivered to the Secretary of the Illinois Department of Human